Please use this identifier to cite or link to this item:
Title: Epidemiology and management of parathyroid gland disorders in Spain over 15 years: A retrospective multicentre analysis
Author: Darbà, Josep
Marsà, Alícia
Keywords: Epidemiologia
Parathyroid glands
Issue Date: 10-Mar-2020
Publisher: Public Library of Science (PLoS)
Abstract: Parathyroid gland disorders are rare conditions with an incidence that displays great variability among populations. Its direct influence in calcium homeostasis originates variable symptoms that affect bone remodelling among other processes. This study aimed to provide data on the epidemiology and characteristics of patients admitted with these disorders in Spain between 2003 and 2017, and to analyse disease management and direct medical costs. Medical records in which a disorder of the parathyroid gland was registered as the admission motive were extracted from a nationwide hospital-discharge database via the Spanish Ministry of Health. Records from 12,903 patients were obtained, with predominance of female patients (74.70%) and of admissions due to hyperparathyroidism (90.23%). The number of patients admitted per year increased over the study period along the incidence of these disorders. The year 2017 incidence of hyperparathyroidism was 2.95 per 10,000, 4.03 per 10,000 in females and 1.37 in males; the same year, the incidence of hypoparathyroidism was 0.17 per 10,000. Length of hospital stay was significantly extended in patients with hypoparathyroidism (7.16 days), admitted mostly due to emergencies. Heart failure was diagnosed in more than 20% of admissions in patients with secondary and tertiary hyperparathyroidism and hypoparathyroidism, while this last group displayed the highest levels of mineral metabolism disruption. Parathyroidectomy was performed in 78.95% of all admissions for primary hyperparathyroidism. The total annual direct medical cost parathyroid gland disorders has increased over the study period, due to the increase of the costs associated to hyperparathyroidism, whereas the cost per patient remained relatively stable, with an average of 3,748, 3,430 and 3,737 for patients with hyperparathyroidism, hypoparathyroidism and other disorders of the parathyroid gland, respectively. This study provides novel data to extend the scarce available knowledge on parathyroid gland disorders' epidemiology and management in Spain.
Note: Reproducció del document publicat a:
It is part of: PLoS One, 2020, vol. 15, num. 3, p. e0230130
Related resource:
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
703050.pdf993.5 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons